The Commanders and Chiefs Steering a company in the right direction is no easy task in today’s highly regulated and competitive environment. These individuals wear the mantle of responsibility well and are the guiding forces of ethics, good corporate citizenship, and strategic vision for their companies. The Risk Takers The entrepreneurial spirit runs deep in these industry vanguards as they carve out new market niches and provide solutions and technologies to improve the healthcare process. The Researchers & Scientists Without the individuals who are dedicated to the science, research, and chemistry of what makes compounds and devices work effectively and safely, the R&D pipelines would be empty and millions of patients would not have the medicines they need. The Brand Builders From advertising to marketing to communications to market research, these brand builders are lifting their art to new heights. The Technologists These technology leaders are taking computer-based and enabled solutions to the next plateau and in doing so they are reducing the time needed to conduct clinical trials, cutting the cost of clinical development, and ensuring that the products that do make it to market are properly evaluated for safety and risk outcomes. Each of these inspiring technologists shares the same goal: improving the lives of millions of people. The Mentors These outstanding individuals unselfishly give of their time and provide their insights to mentor the next generation of business leaders. The Change Agents Not content with the status quo, these individuals have decided to shift the paradigm in their fields and are impacting business processes, technologies, and strategies across the life-sciences industry. In Every Issue Letter from the Editor TPNA’s Mark Booth believes leaders need to articulate the vision to achieve success. Palio’s Guy Mastrion enjoys pushing beyond creative boundaries. Columbia MedCom’s Kathleen Case believes every conversation can be life-changing. Seeing the picture is key, according to Tracy Doyle of Phoenix Holding Group. etrials’ Dr. Rick Piazza believes in being part of the solution. Novartis’ John Talanca Jr. is ahead of his time. July/August 2006

Download PDF